Alcon AG | ALC - Interest Expense On Debt


Alcon AG reported $52M in Interest Expense on Debt for its fiscal quarter ending in March of 2026.





Interest Expense On Debt Change Date
AstraZeneca USD 484M 181M Dec/2025
Bayer EUR 675M 87M Dec/2025
Essilor EUR 168M 21M Dec/2025
Fresenius EUR 81M 5M Sep/2025
Fresenius Medical Care EUR 79M 6M Mar/2026
GlaxoSmithKline GBP 167M 21M Mar/2026
GRIFOLS EUR 141.43M 61.28M Jun/2025
Lonza CHF 84M 14M Jun/2025
Merck EUR 104M 17M Mar/2026
Novartis USD 343M 39M Mar/2026
Philips EUR 83M 26M Mar/2026
Roche Holding CHF 304M 7.5M Jun/2025
Sanofi EUR 178M 203M Mar/2026
Smith & Nephew USD 69M 1000K Dec/2025
Sonova Holding CHF 24.2M 3.7M Jun/2025
UCB EUR 49M 29M Dec/2025